Enduring Hearts funds research to increase longevity and improve the quality of life for children with a transplanted heart.
Heart transplantation is a life-saving procedure for over 10,000 children born with inoperable heart defects or that later suffer from heart failure caused by cardiomyopathy or other disorders. Currently a heart transplant is not a cure, but a bridge to life. The average lifespan of a transplanted heart is less than 20 years. We believe a child’s heart transplant should last a life, which is why we fund the critical research needed to eliminate rejection, prevent life-threatening complications, and reduce the risk of needing a second transplant, giving each of these extraordinary kids a chance to live the future they deserve.
We envision a world where every child who needs a new heart received one that lasts a lifetime.
We know the transplant process can feel isolating, but you’re not alone. Join our Enduring Hearts family for support.
Our Scientific Advisory Committee, Board of Directors, and Review Panel work tirelessly to advance our research.
We aim to drive leading-edge research to help children with heart transplants live longer, healthier lives.
The Gahan family established Enduring Hearts on April 17, 2013 in honor of their daughter, Mya. They wanted to ensure that all children that received a heart transplant would have the chance to live a longer, healthier life. Enduring Hearts operates as a 501(c)3 national non-profit organization and is the only non-profit dedicated to funding pediatric heart transplant research.
Our Scientific Advisory Committee (SAC) is a critical part of the team at Enduring Hearts. The SAC is comprised of top pediatric cardiologists and immunologists from highly esteemed institutions with many years of both patient care and clinical research. The SAC peer-reviews grants several times a year and helps provide invaluable input that enables us to dedicate funds to the most promising research that will save lives for kids who are alive TODAY.
Congratulations to our 2024 Corporate Award recipient, Kyndryl U.S. Kyndryl US is celebrating 2 years of partnership with Enduring Hearts, a non-profit focused on pediatric heart transplant research. In that time, Kyndryl has provided over 1400 volunteer hours delivering projects that accelerate technology modernization, advancement of research and diagnostic power via data science, improved engagement with heart transplant families via design strategy, and given $50,000 in direct donations.
.png)
.png){kind=logo}
.jpg)
